Kala Pharmaceuticals's total assets for Q1 2025 were $48.25M, a decrease of -13.03% from the previous quarter. KALA total liabilities were $42.54M for the fiscal quarter, a -1.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.